Krsnaa Diagnostics Ltd
NSE:KRSNAA
Relative Value
The Relative Value of one KRSNAA stock under the Base Case scenario is 1 078.53 INR. Compared to the current market price of 575.95 INR, Krsnaa Diagnostics Ltd is Undervalued by 47%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
KRSNAA Competitors Multiples
Krsnaa Diagnostics Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IN |
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
18.1B INR | 3.1 | 31.7 | 13.2 | 26.3 | ||
US |
Cigna Corp
NYSE:CI
|
104.3B USD | 0.5 | 20.2 | 10.3 | 13.8 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.6B EUR | 0.5 | 20.1 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
86.9B USD | 0.2 | 10.4 | 8.9 | 8.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22B EUR | 1.1 | 44.1 | 10.3 | 24.5 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.2B USD | 1.4 | 39.7 | 12.1 | 18.2 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | 0.7 | -26.2 | 10 | 22.4 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.5B USD | 1.7 | 18.4 | 10.9 | 14.7 | ||
US |
DaVita Inc
NYSE:DVA
|
12.3B USD | 1 | 17.7 | 8.6 | 12.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 0.6 | 22.7 | 6.8 | 16.1 | |
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |